Researchers study identified which gene fusions are critical for the growth of cancer cells and highlight a new drug target for multiple cancers. Their results suggested that while nearly 90% of the thousands of gene fusions analyzed are probably not important for cancer cell survival, some may have functional relevance and offer up new opportunities for drug repurposing or new drug development.